Clinical Oncology CESR Portfolio Guide

• Aware of public-health issues including population health, social detriments of health and global health perspectives
• Aware of and adheres to the GMC professional requirements
• Demonstrates effective clinical leadership
• Keeps practice up to date through learning and teaching

• Aware of national legislation and legal responsibilities, including safeguarding vulnerable groups
• Behaves in accordance with ethical and legal requirements
• Demonstrates ability to lead the clinical team in ensuring that medical legal factors are considered openly and consistently

• Demonstrates knowledge of wide breadth of advanced communications skills, both in a clinical setting and when communicating with colleagues
• Communicates clearly with patients and carers in a variety of settings, demonstrating effective consultation skills
• Shares decision-making by informing the patient, prioritising the patient’s wishes, and respecting the patient’s beliefs, concerns and expectations

• Understands basic Human Factors principles and practice at individual, team, organisational and system levels
• Raises and escalates concerns where there is an issue with patient safety or quality of care
• Makes patient safety a priority in clinical practice
• Demonstrates commitment to learning from patient-safety investigations and complaints

• Demonstrates knowledge of principles of research methods
• Contributes in research projects at local governance or national, international meetings and/or publications in peer-review journals
• Demonstrates application of evidence in clinical practice
• Participates in clinical trial activities

• Shows understanding of teaching skills
• Delivers effective feedback with an action plan
• Delivers effective teaching and training to medical students, junior doctors and other healthcare professionals
• Is able to act a clinical supervisor to doctors in earlier stages of training

• Demonstrates knowledge and understanding of the design and organisation of clinical trials and the relevant statistical methodology
• Demonstrates knowledge and understanding of the physics relevant to radiotherapy
• Demonstrates knowledge of cancer biology at a molecular and cellular level and understands how this translates into targets for systemic anti-cancer treatments

• Safely assesses and manages the immediate and ongoing care of patients presenting acutely with complications of cancer and its treatment
• Coordinates targeted investigation and rapid triage of patients presenting with a possible new diagnosis of malignancy
• Understands the local and regional Acute Oncology Service and communicates effectively between the elements of the service
• Leads the Acute Oncology team when appropriate to monitor, maintain and develop a high-quality service

• Promptly identifies the acutely deteriorating patient, institutes the appropriate initial medical management and seeks appropriate advice
• Ensures continuity of patient care through safe and effective handover to hospital and community-based teams
• Has managed complex cases where decision-making was dependent on collaboration with other specialities in the context of an acutely deteriorating patient

• Illustrates discussion at MDT, for example, via correspondence or MDT summaries with direct reference to the applicant's contribution
• Participates in discussions at MDT where current guidelines/protocols have limited application
• Recognises limits of clinical guidelines in complex cases
• Recommends treatment plan for complex patients for all tumour sites

• Determines when genetic testing and/or referral for genetic counselling is appropriate
• Accurately assesses the role of all treatment modalities relevant to the individual patient and ensures multidisciplinary team involvement
• Formulates a holistic patient-centred diagnostic and management plan
• Selects the most appropriate treatment regimen and associated supportive measures according to the best available evidence

• Selects the most appropriate SACT regimen and associated supportive measures for the clinical situation
• Applies the knowledge of mechanisms of action and treatment toxicities to pre-empt, monitor and manage these in patients receiving SACT
• Assesses and reports SACT toxicity according to regulatory and, where relevant, research governance processes
• Collaborates effectively with members of the multidisciplinary team when patients are receiving SACT

• Recognises the factors affecting global cancer health inequalities and the social determinants of health
• Promotes survivorship following cancer treatment
• Proactively manages and educates patients about the long-term sequelae of cancer treatments
• Provides specialist advice to other health professionals regarding cancer risks and appropriate investigation of patients following cancer treatment

• Demonstrates capability to utilise multimodality imaging for Target Volume definition and OAR outlining in practice
• Recognises the benefit of peer review
• Illustrates complex decision-making when undertaking outlining
• Undertakes Radiation Therapy Quality Assurance (RTQA) through a QA process and/or peer review in practice

• Identifies and organises appropriate investigations and procedures required prior to treatment
• Accurately determines appropriate target volumes and organs at risk for the chosen regimen of radical radiotherapy
• Determines the most appropriate dose/fractionation regime for the clinical situation and patient factors, including concomitant systemic therapy
• Critically evaluates a radiotherapy treatment plan

• Is able to describe clinical reasoning for determining palliative treatment strategy
• Demonstrates capability to undertake RT planning for cases with palliative intent
• Demonstrate advanced level clinical decision making e.g. justification of approach in cases of re-irradiation
• Capability to apply advanced level skills e.g. applying BED calculation for re-irradiation, compromising treatment volume coverage to meet OAR constraints or reduce toxicity

• Is able to identify patients suitable for treatment with unsealed radio-isotope therapy
• Understands the radiation protection measures required following therapy and is able to communicate them appropriately
• Practices holistically and considers patient factors and preferences in choice of treatment
• Is able to recognise and manage any acute and late complications of treatment

• Is able to identify patients suitable for brachytherapy treatment based on evidence, availability and patient factors
• Communicates effectively with the wider team to ensure the availability of all required facilities and personnel
• Understands the radiation protection measures required following a brachytherapy procedure and is able to communicate them appropriately
• Understands and applies legislation governing the use of sealed brachytherapy sources in hospitals in the UK

• Understands and adheres to the laws, frameworks and guidelines that govern the set-up and delivery of clinical trials
• Understands and adheres to trial protocols
• Understands the roles and responsibilities of national organisations involved in oncology trials, including radiotherapy trials quality assurance (RTTQA)
• Demonstrates knowledge of available new radiotherapy techniques and potential benefits and risks

Currency Window

Evidence of skills or experience gathered from your clinical practise more than five years ago (WTE) should not be submitted. If you are currently working less than full time (LTFT) and wish to extend the time period of your submitted evidence, it is important you provide appraisals and workplace based assessments to cover this period.

Evidence Volume

Most applications contain no more than 150 uploaded documents.